Similar articles for PMID: 30470991

Year	Number of Results
1994	1
1996	1
1997	1
1998	1
2001	1
2002	1
2003	1
2005	1
2006	7
2007	2
2008	1
2009	3
2010	3
2011	3
2012	6
2013	7
2014	12
2015	18
2016	16
2017	16
2018	16
2019	16
2020	12
2021	11
2022	7
2023	1
2024	0

1

SEOM clinical practice guideline: management and prevention of febrile neutropenia in adults with solid tumors (2018).

Carmona-Bayonas A, Jimenez-Fonseca P, de Castro EM, Mata E, Biosca M, Custodio A, Espinosa J, Vázquez EG, Henao F, Ayala de la Peña F. Carmona-Bayonas A, et al. Clin Transl Oncol. 2019 Jan;21(1):75-86. doi: 10.1007/s12094-018-1983-4. Epub 2018 Nov 23. Clin Transl Oncol. 2019. PMID: 30470991 Free PMC article.

2

Common misconceptions in the prognostic evaluation of clinically stable patients with febrile neutropenia and solid tumors.

Carmona-Bayonas A, Jiménez-Fonseca P. Carmona-Bayonas A, et al. Clin Transl Oncol. 2019 Aug;21(8):1112-1114. doi: 10.1007/s12094-018-02020-8. Epub 2019 Jan 3. Clin Transl Oncol. 2019. PMID: 30607791 No abstract available.

3

Granulocyte colony-stimulating factors in the prevention of febrile neutropenia: review of cost-effectiveness models.

Fust K, Parthan A, Maschio M, Gu Q, Li X, Lyman GH, Tzivelekis S, Villa G, Weinstein MC. Fust K, et al. Expert Rev Pharmacoecon Outcomes Res. 2017 Feb;17(1):39-52. doi: 10.1080/14737167.2017.1276829. Epub 2017 Jan 20. Expert Rev Pharmacoecon Outcomes Res. 2017. PMID: 28064553 Review.

4

Colony-stimulating factors for the management of neutropenia in cancer patients.

Dale DC. Dale DC. Drugs. 2002;62 Suppl 1:1-15. doi: 10.2165/00003495-200262001-00001. Drugs. 2002. PMID: 12479591 Review.

5

Application of the MASCC and CISNE Risk-Stratification Scores to Identify Low-Risk Febrile Neutropenic Patients in the Emergency Department.

Coyne CJ, Le V, Brennan JJ, Castillo EM, Shatsky RA, Ferran K, Brodine S, Vilke GM. Coyne CJ, et al. Ann Emerg Med. 2017 Jun;69(6):755-764. doi: 10.1016/j.annemergmed.2016.11.007. Epub 2016 Dec 29. Ann Emerg Med. 2017. PMID: 28041827

6

Comparison of the MASCC and CISNE scores for identifying low-risk neutropenic fever patients: analysis of data from three emergency departments of cancer centers in three continents.

Ahn S, Rice TW, Yeung SJ, Cooksley T. Ahn S, et al. Support Care Cancer. 2018 May;26(5):1465-1470. doi: 10.1007/s00520-017-3985-0. Epub 2017 Nov 22. Support Care Cancer. 2018. PMID: 29168032

7

[Use of granulocyte-colony stimulating factor(G-CSF)in patients with cancer at high risk of febrile neutropenia on the basis of high age and complications, recommendations for patients receiving radiotherapy, and adverse events because of G-CSF].

Hanada N, Tanaka S, Takahata T, Sato A. Hanada N, et al. Gan To Kagaku Ryoho. 2014 Jun;41(6):702-6. Gan To Kagaku Ryoho. 2014. PMID: 25129083 Japanese.

8

2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours.

Aapro MS, Bohlius J, Cameron DA, Dal Lago L, Donnelly JP, Kearney N, Lyman GH, Pettengell R, Tjan-Heijnen VC, Walewski J, Weber DC, Zielinski C; European Organisation for Research and Treatment of Cancer. Aapro MS, et al. Eur J Cancer. 2011 Jan;47(1):8-32. doi: 10.1016/j.ejca.2010.10.013. Epub 2010 Nov 20. Eur J Cancer. 2011. PMID: 21095116

9

EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours.

Aapro MS, Cameron DA, Pettengell R, Bohlius J, Crawford J, Ellis M, Kearney N, Lyman GH, Tjan-Heijnen VC, Walewski J, Weber DC, Zielinski C; European Organisation for Research and Treatment of Cancer (EORTC) Granulocyte Colony-Stimulating Factor (G-CSF) Guidelines Working Party. Aapro MS, et al. Eur J Cancer. 2006 Oct;42(15):2433-53. doi: 10.1016/j.ejca.2006.05.002. Epub 2006 Jun 5. Eur J Cancer. 2006. PMID: 16750358 Review.

10

Accuracy of the Multinational Association of Supportive Care in Cancer (MASCC) and Clinical Index of Stable Febrile Neutropenia (CISNE) scores for predicting serious complications in adult patients with febrile neutropenia: A systematic review and meta-analysis.

Zheng B, Toarta C, Cheng W, Taljaard M, Reaume N, Perry JJ. Zheng B, et al. Crit Rev Oncol Hematol. 2020 May;149:102922. doi: 10.1016/j.critrevonc.2020.102922. Epub 2020 Mar 3. Crit Rev Oncol Hematol. 2020. PMID: 32244162

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

139 results

Results by year